Symmetry Technologies Inc (SMMR)

[Screech691]

Business Description
Symmetry Technologies, Inc. is isolating compounds that, it believes, will induce apoptosis in senescent cells, stimulate stem cell growth, and suppress herpes activity. The Company believes that by clearing tissues with short average telomere length and stimulating longer telomere cell growth, including differentiation from stem cell populations, while ameliorating the effects of HSV activity, they will produce an effect that is tantamount to cell rejuvenation. Symmetry is accomplishing these biological tasks using compounds that have been accepted as safe for human consumption and already approved for human use, believing that the "art" will be in producing the desired effect using combinations of such compounds. "The process of creating this product has been very interesting," said President Chad Reed. "This is the first of many products we hope to bring to the marketplace." The Company's research in this area is being pursued in cooperation with Quantum Bit Induction Technology, Inc. (www.quantumbit.com) and a small group of Ph.D. biologists.